These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

813 related articles for article (PubMed ID: 32330214)

  • 1. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charge-switchable cell-penetrating peptides for rerouting nanoparticles to glioblastoma treatment.
    Mendes M; Nunes S; Cova T; Branco F; Dyrks M; Koksch B; Vale N; Sousa J; Pais A; Vitorino C
    Colloids Surf B Biointerfaces; 2024 Sep; 241():113983. PubMed ID: 38850741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailored polymer-lipid hybrid nanoparticles for the delivery of drug conjugate: dual strategy for brain targeting.
    Agrawal U; Chashoo G; Sharma PR; Kumar A; Saxena AK; Vyas SP
    Colloids Surf B Biointerfaces; 2015 Feb; 126():414-25. PubMed ID: 25601092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
    Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
    Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
    Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
    Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumortropic adipose-derived stem cells carrying smart nanotherapeutics for targeted delivery and dual-modality therapy of orthotopic glioblastoma.
    Huang WC; Lu IL; Chiang WH; Lin YW; Tsai YC; Chen HH; Chang CW; Chiang CS; Chiu HC
    J Control Release; 2017 May; 254():119-130. PubMed ID: 28336375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment.
    Pereira NRC; Loiola RA; Rodrigues SF; de Oliveira CP; Büttenbender SL; Guterres SS; Pohlmann AR; Farsky SH
    Int J Nanomedicine; 2018; 13():4563-4573. PubMed ID: 30154652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
    Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
    Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
    Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
    Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood-brain barrier and glioma cells.
    Bruun J; Larsen TB; Jølck RI; Eliasen R; Holm R; Gjetting T; Andresen TL
    Int J Nanomedicine; 2015; 10():5995-6008. PubMed ID: 26451106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.
    Zhang Y; Fu X; Jia J; Wikerholmen T; Xi K; Kong Y; Wang J; Chen H; Ma Y; Li Z; Wang C; Qi Q; Thorsen F; Wang J; Cui J; Li X; Ni S
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43408-43421. PubMed ID: 32885649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual functional nanoparticles efficiently across the blood-brain barrier to combat glioblastoma
    Jin Z; Piao L; Sun G; Lv C; Jing Y; Jin R
    J Drug Target; 2021 Mar; 29(3):323-335. PubMed ID: 33108906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma.
    Nepali K; Hsu TI; Hsieh CM; Lo WL; Lai MJ; Hsu KC; Lin TE; Chuang JY; Liou JP
    Eur J Med Chem; 2021 May; 217():113338. PubMed ID: 33744690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
    Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
    J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy for Drug-Resistant Glioblastoma via Lipid-Polymer Hybrid Nanoparticles Combined with Focused Ultrasound.
    Yang Q; Zhou Y; Chen J; Huang N; Wang Z; Cheng Y
    Int J Nanomedicine; 2021; 16():185-199. PubMed ID: 33447034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
    Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
    Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
    Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S
    Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme.
    Akhter MH; Rizwanullah M; Ahmad J; Amin S; Ahmad MZ; Minhaj MA; Mujtaba MA; Ali J
    Drug Res (Stuttg); 2021 Mar; 71(3):122-137. PubMed ID: 33167048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of ultra-small lipid nanoparticle surface charge for targeting glioblastoma.
    Mendes M; Miranda A; Cova T; Gonçalves L; Almeida AJ; Sousa JJ; do Vale MLC; Marques EF; Pais A; Vitorino C
    Eur J Pharm Sci; 2018 May; 117():255-269. PubMed ID: 29486328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.